Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gabriella Matera

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Pulmonary Pharmacology & Therapeutics|December 20, 2005
Pharmacologic characteristics of prulifloxacinMaria Gabriella Matera
Clinics in Chest Medicine|February 11, 2014
Bronchodilators: current and futureMario Cazzola, Maria Gabriella Matera
The Lancet. Respiratory Medicine|March 14, 2014
N-acetylcysteine in COPD may be beneficial, but for whom?Mario Cazzola, Maria Gabriella Matera
American Journal of Respiratory and Critical Care Medicine|September 18, 2008
Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with cautionMario Cazzola, Maria Gabriella Matera
Chest|October 7, 2018
Rebuttal From Drs Cazzola and MateraMario Cazzola, Maria Gabriella Matera
Med (New York, N.Y.)|August 9, 2025
Efficacy without resolution: A critical appraisal of mepolizumab in eosinophilic COPDMario Cazzola, Maria Gabriella Matera
Chest|June 9, 2026
TQC3721: Expanding the Role of Dual Phosphodiesterase 3/4 Inhibition in COPD ManagementMario Cazzola, Maria Gabriella Matera
Chest|June 10, 2018
Combining Dual Bronchodilation and β-Blockade in Patients With an Overlap Between COPD and Cardiovascular DiseasesMario Cazzola, Maria Gabriella Matera
Chest|October 9, 2021
An Obvious Paradigm: Choosing Bronchodilators and Inhaled Corticosteroids for Their Pharmacologic CharacteristicsMario Cazzola, Maria Gabriella Matera
Current Opinion in Pharmacology|June 4, 2018
Editorial overview: Respiratory: Pulmonary pharmacology - It is time for a breath of fresh airMario Cazzola, Maria Gabriella Matera
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Pulmonary Pharmacology & Therapeutics|December 20, 2005
Pharmacologic characteristics of prulifloxacinMaria Gabriella Matera
Clinics in Chest Medicine|February 11, 2014
Bronchodilators: current and futureMario Cazzola, Maria Gabriella Matera
The Lancet. Respiratory Medicine|March 14, 2014
N-acetylcysteine in COPD may be beneficial, but for whom?Mario Cazzola, Maria Gabriella Matera
American Journal of Respiratory and Critical Care Medicine|September 18, 2008
Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with cautionMario Cazzola, Maria Gabriella Matera
Chest|October 7, 2018
Rebuttal From Drs Cazzola and MateraMario Cazzola, Maria Gabriella Matera
Med (New York, N.Y.)|August 9, 2025
Efficacy without resolution: A critical appraisal of mepolizumab in eosinophilic COPDMario Cazzola, Maria Gabriella Matera
Chest|June 9, 2026
TQC3721: Expanding the Role of Dual Phosphodiesterase 3/4 Inhibition in COPD ManagementMario Cazzola, Maria Gabriella Matera
Chest|June 10, 2018
Combining Dual Bronchodilation and β-Blockade in Patients With an Overlap Between COPD and Cardiovascular DiseasesMario Cazzola, Maria Gabriella Matera
Chest|October 9, 2021
An Obvious Paradigm: Choosing Bronchodilators and Inhaled Corticosteroids for Their Pharmacologic CharacteristicsMario Cazzola, Maria Gabriella Matera
Current Opinion in Pharmacology|June 4, 2018
Editorial overview: Respiratory: Pulmonary pharmacology - It is time for a breath of fresh airMario Cazzola, Maria Gabriella Matera
Pageof 33